Indeed, several, small-scale studies with relatively short follow-up found that dual RAS blockade combining an ACE inhibitor and an ARB may reduce albuminuria more effectively than single blockade with ACE inhibitor or ARB monotherapy in subjects with or without diabetes [9,22–24]. The gene discussed is ACE; the disease is diabetes mellitus.